Diclofenac associated with cardiovascular health risk
A 20-year population-based study has found the use of diclofenac for pain relief is linked to an increased risk of major adverse cardiovascular events...
Systemic corticosteroids for dyspnoea
The effectiveness of systemic corticosteroids for the management of dyspnoea in adults with advanced cancer.
Dyspnoea affects almost 70% of advanced cancer patients at the...
PSA National President opening address at PSA24
Read the transcript of the speech delivered by PSA National President Associate Professor Fei Sim FPS at PSA24 today (2 August).
Ethical lessons for Australian pharmacists from overseas
What ethical lessons do Australian pharmacists need to heed from other countries? A panel of experts at the FIP Congress filled in the blanks.
Pharmacist on the rise
Ayomide Ogundipe’s initiative, commitment to patient-centred care, and leadership while interning at Pharmacy777 in Perth has earned her PSA’s Intern of the Year award.
Ms...
Cost of asthma treatment – a deterrent to use
Cost is a major factor associated with non-adherence to asthma treatment in Australia, recent research revealed. Healthcare providers can assist patients with adherence by...













